Linepharma International is a pharmaceutical company committed to improving sexual and reproductive health by expanding access to safe medication abortion. Founded in 2010, Linepharma is a global leader in the provision of high-quality, stringent regulatory health authority–approved non-surgical abortion products. Of the approximately 73 million abortions that took place around the world each year from 2015 to 2019, an estimated 24 million were deemed unsafe. In line with current scientific data and the World Health Organization’s recommendations, Linepharma aims to make safe abortion and sexual and reproductive health care accessible to as many people as possible, in as many places as possible, regardless of their social, political, or economic circumstances. For more information visit https://www.linepharma.com/